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Paget disease of bone (PDB) is a common disorder characterized by focal abnormalities of increased and disorganized
bone turnover. Genetic factors are important in the pathogenesis of PDB, and previous studies have shown that
the PDB-like bone dysplasia familial expansile osteolysis is caused by activating mutations in the TNFRSF11A gene
that encodes receptor activator of nuclear factor kB (RANK); however, linkage studies, coupled with mutation
screening, have excluded involvement of RANK in the vast majority of patients with PDB. To identify other candidate
loci for PDB, we conducted a genomewide search in 319 individuals, from 62 kindreds with familial PDB, who
were predominantly of British descent. The pattern of inheritance in the study group as a whole was consistent
with autosomal dominant transmission of the disease. Parametric multipoint linkage analysis, under a model of
heterogeneity, identified three chromosomal regions with LOD scores above the threshold for suggestive linkage.
These were on chromosomes 2q36 (LOD score 2.7 at 218.24 cM), 5q35 (LOD score 3.0 at 189.63 cM), and
10p13 (LOD score 2.6 at 41.43 cM). For each of these loci, formal heterogeneity testing with HOMOG supported
a model of linkage with heterogeneity, as opposed to no linkage or linkage with homogeneity. Two-point linkage
analysis with a series of markers from the 5q35 region in another large kindred with autosomal dominant familial
PDB also supported linkage to the candidate region with a maximum LOD score of 3.47 at D5S2034 (187.8 cM).
These data indicate the presence of several susceptibility loci for PDB and identify a strong candidate locus for the
disease, on chromosome 5q35.
Introduction
Paget disease of bone (PDB [MIM 167250 and MIM
602080]) is a common disorder that affects as many as
3% of individuals 55 years of age, in the United King-
dom and in other white populations (Barker 1984; Kanis
1992; Cooper et al. 1999). The disease is characterized
by focal areas of increased osteoclastic bone resorption,
coupled with increased and disorganized formation of
new bone. Although many patients are asymptomatic,
as many as 30% have symptoms related to the disease,
such as bone pain, bone deformity, pathological fracture,
and deafness (Tiegs et al. 2000). Patients with PDB are
also at an increased risk of developing osteosarcoma.
Although this is a rare complication, individuals with
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PDB constitute more than half of all patients 160 years
of age who develop osteosarcomas (Huvos 1986).
The cause of PDB is incompletely understood, but
accumulating evidence suggests that there is a strong
genetic component. Familial clustering is common in
PDB, and 15%–40% of affected individuals have been
reported to have an affected first-degree relative (Sofaer
et al. 1983; Siris et al. 1991; Morales-Piga et al. 1995).
Several families have been described in which PDB is
inherited in an autosomal dominant manner (Morales-
Piga et al. 1995; Cody et al. 1997; Haslam et al. 1998;
Nance et al. 2000; Good et al. 2001), as is the rare
bone dysplasia familial expansile osteolysis (FEO [MIM
174810]), which shares many clinical features with PDB
(Wallace et al. 1989). The gene responsible for FEO was
mapped to chromosome 18q21-22 by Hughes and col-
leagues (1994), and some PDB kindreds were sub-
sequently found to be linked to the FEO region (Cody
et al. 1997; Haslam et al. 1998). Recent studies have
shown that FEO is caused by a 6–amino acid–insertion
mutation affecting the signal peptide region of the re-
ceptor activator of nuclear factor kB (NF-kB) (RANK)
(Hughes et al. 2000). In another family, in which clinical
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examination showed an overlap between the features
of FEO and familial PDB, a 9–amino acid–insertion
mutation was identified in affected individuals within
the same region of the RANK molecule (Hughes et
al. 2000). Subsequent work has shown that linkage
to chromosome 18q21-22 is unusual in familial PDB
(Hocking et al. 2000; Nance et al. 2000; Good et al.
2001), and RANK mutations have been excluded as
a common cause of PDB in a large number of patients
with either familial or sporadic PDB (Sparks et al.
2001; Wuyts et al. 2001). These data indicate that
other genes may be responsible for most cases of fa-
milial PDB. In the present study, we have used a ge-
nomewide search to attempt to identify loci that pre-
dispose to familial PDB.
Patients, Material, and Methods
Family Recruitment and Disease Ascertainment
Families were recruited by a combination of routine
clinic referrals and by advertisements in the Newsletter
of the National Association for Relief of Paget’s Disease
(a patient self-help group based in the United Kingdom).
The study group comprised 319 individuals, of predom-
inantly British descent, from 62 kindreds in which we
were able to recruit a proband and at least one living
relative affected by PDB. Twenty-eight (45%) families
were recruited from the United Kingdom, 17 (27%) from
Australia, 14 (23%) from New Zealand, and 1 (2%)
each from the United States, Canada, and Hungary. The
mean (SD) family size was 5.4 (3.7) individuals, with a
range of 2–24. Clinical features and patterns of inheri-
tance for 50 of the 62 families included in the present
study have been described in more detail elsewhere
(Hocking et al. 2000). In agreement with the findings of
numerous other investigators (McKusick 1976; Morales-
Piga et al. 1995; Cody et al. 1997; Haslam et al. 1998;
Nance et al. 2000; Good et al. 2001), we found that the
pattern of inheritance in larger families was consistent
with that of an autosomal dominant gene. Although it
was not possible to unequivocally determine the inher-
itance pattern in smaller families, such as affected sib
pairs, we found that 56% of at-risk individuals in the
present study had developed PDB by the age of 55 years,
with an equal frequency in men and women, in keeping
with hypothesis that the disease is inherited in an au-
tosomal dominant manner. As in one study reported else-
where (Hocking et al. 2000), we found no significant
difference in the frequency of disease inheritance from
paternal and maternal sources in subjects for whom pa-
rental data were available (data not shown). A full set
of pedigree drawings for families included in the present
study is available at the University of Aberdeen Web site.
We screened for the presence of PDB by measurement
of serum total alkaline phosphatase (AP), because AP
values are almost invariably elevated in untreated pa-
tients with PDB (Kanis 1992). Individuals 155 years old
in whom serum AP values were !65 U/liter (reference
range 40–105 U/liter) were considered unaffected, where-
as those with AP values in the high normal range (65–
105 U/liter) or with frankly elevated values (1105 U/
liter) were considered to have an unclear diagnosis and
were investigated further. These individuals were defined
as affected if evidence of PDB was found through ra-
dionuclide bone-scan examinations and/or skeletal ra-
diographs. Unless PDB had been confirmed radiologi-
cally or scintigraphically, individuals !55 years of age
were considered to have an unclear diagnosis, even in
the presence of normal AP levels (!65 U/liter), to take
account of fact that PDB does not usually present clin-
ically until the fifth or sixth decade (Kanis 1992).
Limited genotyping, for one candidate locus identified
by the genomewide search, was performed in an addi-
tional large U.S. family that had autosomal dominant
inheritance of PDB. This family comprised 18 individ-
uals, of whom 11 were affected with the disease.
All subjects gave informed consent to being included
in the studies, which were approved by the Grampian
research ethics committee and the research ethics com-
mittees of the other contributing centers.
Genotyping and Linkage Analysis
Genotyping was carried out on DNA extracted from
venous blood using the Nucleon II kit (Scotlab), ac-
cording to the manufacturer’s instructions. The ge-
nomewide screen was performed using 366 polymorphic
microsatellite markers spaced, on average, at 9-cM in-
tervals throughout the autosomes (ABI Prism Linkage
Mapping Set MD-10). The order of markers and the
distance between markers were obtained from the
Marshfield database. Markers were genotyped by stan-
dard techniques on a 377 automated DNA sequencing
system (Applied Biosystems). Alleles were scored man-
ually, using ABI Genescan and Genotyper software, and
were binned using the Linkage Designer program. Par-
ametric linkage analysis was performed using Genehun-
ter version 1.3 (Kruglyak et al. 1996), under models of
both homogeneity and heterogeneity, assuming an au-
tosomal dominant mode of inheritance, with penetrance
set at 90% for individuals aged 55 years. The disease-
gene frequency was set at .00465, and the phenocopy
rate was set at .02635, to reflect the estimated prevalence
of familial and sporadic PDB in the U.K. population
(Sofaer et al. 1983; Cooper et al. 1999). Genehunter 1.3
was also used to calculate nonparametric linkage (NPL)
statistics. For linkage analysis under a model of heter-
ogeneity, the fraction of pedigrees linked (a) was allowed
to vary until a maximized LOD score was reached. Loci
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Figure 1 Candidate loci for familial PDB identified by ge-
nomewide search. Data are shown from chromosomes 2, 5, and
10, where maximized LOD scores yielded values 1.9, under a
model of heterogeneity. The position of selected markers spanning
the regions of interest are indicated.
in which maximized LOD scores exceeded the threshold
for suggestive linkage (11.9) were also analyzed for link-
age heterogeneity, using the HOMOG program. The
power of the family set to detect linkage was simulated
using the SLINK program, in which genotypes were sim-
ulated for a marker with eight alleles of equal frequency.
This showed that the cohort had 100% power to detect
significant linkage (i.e., LOD score3.3) under a model
of homogeneity and that 64% had power to detect sig-
nificant linkage under a model of heterogeneity (50%
of families linked). Corresponding power values for
suggestive linkage (LOD score 1.9) were 100% and
89%, respectively. Two-point linkage analysis of a can-
didate region on chromosome 5q35 was conducted with
the use of the MLINK and ILINK programs from the
Linkage Analysis Package version 5.1 (Lathrop and La-
louel 1984), in one large family that was not included
in the genome search. Positional candidate genes from
the regions of interest were identified using the Ensembl
Database.
Results
Linkage analysis under a model of homogeneity iden-
tified only one locus where the LOD score was above
the threshold for suggestive linkage, and this was on
chromosome 5q35 between the markers D5S400 and
D5S408 (LOD score 1.9). Linkage analysis under a
model of heterogeneity identified three loci where max-
imized LOD scores exceeded the threshold for suggestive
linkage (fig. 1). These were on chromosome 5q35 at
189.63 cM between the markers D5S400 and D5S408
(LOD score 3.0 at ), on chromosome 2q36 atap .637
218.24 cM between the markers D2S126 and D2S396
(LOD score 2.7 at ), and on chromosomeap .470
10p13 at 41.43 cM between the markers D10S1653 and
D10S548 (LOD score 2.6 at ). NPL analysisap .542
showed the following maximum scores at these loci: 2.18
( ) at 193.77 cM on chromosome 5q35, closePp .008
to D5S408; 2.38 ( ) at 225.3 cM on chromo-Pp .004
some 2q36, between D2S126 and D2S396; and 2.40
( ) at 38.2 cM on chromosome 10q13, close toPp .004
D10S1653.
To investigate the candidate loci further, heteroge-
neity testing was also performed using the HOMOG
program on multipoint LOD scores from the regions of
interest generated by Genehunter (table 1). For the can-
didate locus on chromosome 2q36, there was no evi-
dence to support linkage under a model of homogeneity,
but there was evidence of linkage under a model of
heterogeneity, between the markers D2S126 and
D2S396 at a . Hypothesis testing showed sig-ap .466
nificant evidence of linkage with heterogeneity ( 2x p
, 2 df, ). For the candidate locus on chro-12.5 Pp .002
mosome 5q35, there was also evidence of linkage under
a model of heterogeneity between the markers D5S400
and D5S408 at . There was also some evi-ap 0.680
dence of linkage under a model of homogeneity at this
locus, but hypothesis testing favored a model of linkage
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Table 1
Heterogeneity Testing of Candidate Loci for Familial PDB
Locus and
Hypothesesa Max LnLb a
Map Position
(cM)
2q36:
Hypotheses:
H2 6.235 .466 218.24
H1 0 (1) …
H0 (0) (0) …
df x2 LR
Hypothesis testing:
H2 vs. H1 1 12.469
c 510.029
H1 vs. H0 1 0 1.000
H2 vs. H0 2 12.469
c 510.029
Max LnL a
Map Position
(cM)
5q35:
Hypotheses:
H2 6.883 .680 189.63
H1 4.537 (1) 189.63
H0 (0) (0) …
df x2 LR
Hypothesis testing:
H2 vs. H1 1 4.692 10.444
H1 vs. H0 1 9.074
d 93.432
H2 vs. H0 2 13.766
e 975.755
Max LnL a
Map Position
(cM)
10p13:
Hypotheses:
H2 6.064 .546 41.43
H1 0 (1) …
H0 (0) (0) …
df x2 LR
Hypothesis testing:
H2 vs. H1 1 12.128
c 430.063
H1 vs. H0 1 0 1.000
H2 vs. H0 2 12.128
c 460.063
NOTE.—Numbers in parentheses show values that are set by
definition.
a H2p linkage, under the model of heterogeneity; H1p linkage,
under the model of homogeneity; and H0 p no linkage.
b Max LnL p natural logarithm of maximized LOD score.
c .Pp .002
d .Pp .003
e .Pp .001
with heterogeneity ( ; 2 df; ; likeli-2x p 13.7 Pp .001
hood ratio (LR) of 975.75) over the model of linkage
with homogeneity ( , 1 df, ;2x p 9.1 Pp .003 LRp
). For the locus on chromosome 10p13, there was93.4
evidence of linkage under a model of heterogeneity be-
tween the markers D10S1653 and D10S548 at ap
. Hypothesis testing showed significant evidence0.546
of linkage with heterogeneity ( ; 2 df;2x p 12.1 Pp
)..002
To test candidacy of the chromosome 5q35 region
further, we analyzed a series of markers from the 5q35
locus in a large family from the United States that had
autosomal dominant inheritance of PDB (fig. 2). This
showed positive LOD scores for several markers across
the candidate region, with a maximum LOD score of
3.47 at D5S2034 (table 2).
Discussion
In the present study, we performed an autosomal genome
screen for chromosomal regions that contain suscepti-
bility genes for familial PDB. When the data were an-
alyzed under a model of homogeneity, we identified only
one possible candidate locus for the disease, on chro-
mosome 5q35, where the LOD score (1.9) just reached
the threshold for suggestive linkage. Analysis of the data
under a model of heterogeneity, however, identified three
loci where LOD scores exceeded the threshold for sug-
gestive linkage. The highest LOD score was on chro-
mosome 5q35, where a maximum value of 3.0 was
found at 189.36 cM between the markers D5S400 and
D5S408. A second region was found on chromosome
2q36, where the LOD score was 2.7 at 218.24 cM, be-
tween the markers D2S126 and D2S396. A third region
was on chromosome 10p13, where the LOD score was
2.6 at 41.43 cM, between the markers D10S1653 and
D10S548. In agreement with previous reports, we found
no evidence of linkage to the FEO locus (PDB2) on chro-
mosome 18q21-22 (Hocking et al. 2000; Nance et al.
2000; Good et al. 2001), nor did we find evidence of
linkage to the human leukocyte antigen (HLA) (PDB1)
locus on chromosome 6p21 (Nance et al. 2000; Good
et al. 2001). Other candidate genes for PDB include
RANK ligand (RANKL), which has been mapped to
chromosome 13q14, and osteoprotegerin (OPG), which
has been mapped to chromosome 8q24. RANKL—
which is expressed on the surface of bone marrow
stromal cells, osteoblasts, and activated T-cells—
stimulates osteoclast formation and activity by binding
to RANK and activating NF-kB and c-Jun N-terminal
kinase–signaling pathways (Hofbauer et al. 2000). OPG
is an inhibitor of osteoclastogenesis, which acts as a
soluble decoy receptor for RANKL (Hofbauer et al.
2000). In a study reported elsewhere, we found a positive
association between a polymorphism in intron 2 of the
OPG gene and sporadic PDB, but we did not detect any
disease-specific mutations of OPG in familial or sporadic
PDB (Wuyts et al. 2001). We have similarly failed to
detect any disease-specific mutations of RANKL in fa-
milial and sporadic PDB (L.J.H. and S.H.R., unpub-
lished data). In keeping with these observations, we
found no evidence of linkage to chromosomes 8q24 or
13q14 in this cohort of patients with familial PDB.
The strongest candidate locus for PDB found in the
present study was a 24-cM region on chromosome 5q35
between D5S400 and D5S2006. Two-point linkage
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Figure 2 Pedigree structure and haplotypes spanning the 5q35 region in an extended U.S. kindred with familial PDB. A haplotype
shared by most affected members of the kindred is boxed. Blackened symbols denote affected individuals, and unblackened symbols
denote unaffected individuals. Unblackened symbols that contain a question mark indicate individuals whose diagnosis was unclear.
studies in a large family from the United States sup-
ported linkage to the 5q35 region, but two individuals
(subjects IV.14 and V.2) who had signs of PDB did not
share the same haplotype as other affected individuals
in the family. There are three possible explanations for
this observation. First, the disease could have occurred
as a result of a new mutation. The contribution of this
explanation to the findings observed is difficult to de-
termine, because the genes responsible for late-onset
PDB are unknown and because the mutation rate has
not been determined. A second explanation is that in-
dividuals IV.14 and V.2 could have had a nongenetic
cause of PDB. This is clearly possible, because 60%–
85% of PDB cases appear to be sporadic (Sofaer et al.
1983; Siris et al. 1991; Morales-Piga et al. 1995). It has
been suggested that sporadic PDB may occur as a result
of a slow-virus infection of osteoclasts with paramyxo-
viruses, such as measles and canine distemper (Siris
1996; Kurihara et al. 2000), although this issue remains
controversial (Helfrich et al. 2000). Other environmen-
tal factors that have been identified as triggers of the
disease include repetitive mechanical loading of affected
bones (Solomon 1979) and low dietary calcium intake
(Siris 1994). The third explanation is that individuals
IV.14 and V.2 could have inherited a different disease
gene from the grandmother (individual III.4), whose
phenotype was unknown. This is certainly possible, in
view of the fact that PDB is a common condition that
shows evidence of locus heterogeneity, as demonstrated
by the present study and by studies done by other groups
(Haslam et al. 1998; Hocking et al. 2000; Nance et al.
2000; Good et al. 2001). Further work will be required
to define the relative contribution of these three possible
explanations to the findings observed in this family.
Several genes within the 5q35 region are known to
be expressed in bone and/or to play a role in signaling
mechanisms that may be relevant to the pathogenesis
of PDB. They include GPRK6, a G-protein–coupled
receptor kinase; MAPK9, a mitogen-activated kinase;
DUSP1, a protein phosphatase involved in negative reg-
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Table 2
Two-Point LOD Scores for Chromosome 5q35 Markers in a Large Kindred with Familial
PDB
MARKER
DISTANCE
(cM)
LOD SCORE AT v p
Zmax v0 .01 .05 .10 .20 .30 .40
D5S429 179.11 .45 .68 1.17 1.38 1.30 .93 .44 1.40 .129
D5S498 184.66 .30 .50 .92 1.12 1.08 .76 .34 1.15 .135
D5S2034 187.81 3.47 3.39 3.09 2.69 1.90 1.13 .44 3.47 .000
D5S2030 190.97 1.32 1.44 1.72 1.78 1.51 1.01 .45 1.79 .088
D5S2073 194.88 2.31 2.35 2.34 2.15 1.59 .94 .35 2.37 .025
D5S408 195.49 1.93 2.02 2.22 2.21 1.84 1.26 .58 2.24 .071
D5S2006 197.54 1.47 1.60 1.82 1.81 1.45 .90 .34 1.84 .071
ulation of MAP kinase signaling;MSX2, a gene involved
in skull development; ATP6H, a subunit of the vacuolar
protein pump; and BNIP1, a protein involved the reg-
ulation of apoptosis. Further studies will be required to
define the role that these and other genes play in the
pathogenesis of PDB in families that show 5q35 linkage.
Although the candidate locus on chromosome 10p13
does not contain any obvious candidate genes for PDB,
the chromosome 2q36 locus contains several, including
members of the insulinlike growth factor–binding pro-
tein family (IGFBP2 and IGFBP5); the Indian Hedgehog
(IHH) protein; and C-type natriuretic peptide precursor
(NPPC).
In summary, we have identified three potential sus-
ceptibility loci for PDB on chromosomes 2q36, 5q35,
and 10p13; and, for each of these loci, we found evi-
dence of genetic heterogeneity, indicating that the phe-
notype of PDB may occur as a result of mutations or
polymorphisms in several different genes.
At present, the relative contribution of these loci
to the pathogenesis of familial PDB in general is dif-
ficult to assess. For the chromosome 5q35 locus, max-
imized LOD score analysis, with the use of Gene-
hunter, coupled with formal heterogeneity testing
using HOMOG, indicated that disease-related genes in
63.7%–68.0% of families may have been linked to the
region of interest. Corresponding figures for the chro-
mosome 2q36 locus were 46.6%–47.0%, and those for
the chromosome 10p13 locus 54.0%–54.6%. The total
for these three loci is 1100%, because many of the
smaller families showed evidence of linkage to more
than one locus. This is a limitation of our study and
simply reflects the fact that most of the families were
too small to confirm or exclude linkage to a specific
locus.
Positional cloning studies are in progress to try to
identify the genes that are responsible for the occur-
rence of PDB within these chromosomal regions. The
identification of these genes will give important in-
sights into the mechanisms that underlie the abnor-
mal bone remodeling that characterizes PDB, and
this, in turn, should lead to better strategies for pre-
vention and treatment.
Note added in proof.—Since the submission of the
present manuscript, Laurin et al. (2001) have reported
evidence of candidate loci for familial Paget disease on
chromosome 5q35 and 5q31.
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